TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Elexir Pharma AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
108,935
|
82,371
|
79,145 |
Financial expenses |
11
|
49
|
13 |
Earnings before taxes |
12,407
|
11,345
|
12,047 |
EBITDA |
12,541
|
11,516
|
12,373 |
Total assets |
45,962
|
33,095
|
29,696 |
Current assets |
42,385
|
32,408
|
29,013 |
Current liabilities |
13,282
|
9,091
|
7,881 |
Equity capital |
31,272
|
23,043
|
19,416 |
- share capital |
51
|
47
|
49 |
Employees (average) |
15
|
10
![]() |
10 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.0%
|
69.6%
|
65.4% |
Turnover per employee |
7,262
|
8,237
|
7,914 |
Profit as a percentage of turnover |
11.4%
|
13.8%
|
15.2% |
Return on assets (ROA) |
27.0%
|
34.4%
|
40.6% |
Current ratio |
319.1%
|
356.5%
|
368.1% |
Return on equity (ROE) |
39.7%
|
49.2%
|
62.0% |
Change turnover |
20,720
|
5,605
|
13,416 |
Change turnover % |
23%
|
7%
|
20% |
Chg. No. of employees |
5
|
0
|
3 |
Chg. No. of employees % |
50%
|
0%
|
43% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.